Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Navier Medical and five other biotechs receive $13.5M in CUREator+ grants to advance AI health and cancer technologies towards market.
PRIVATEAug 13, 2026•about 4 hours ago
Amount Raised
$13.5 Million
Round Type
Venture - Series Unknown
Description
Six biomedical and health tech startups are sharing in $13.5 million from a second investment round from the MRFF-backed CUREator+ program. The startups span inflammatory disease, cancer, cardiovascular disease, neurological disorders, and AI-enabled digital health. CUREator+ offers non-dilutive capital and commercialisation support to accelerate the development of medical innovations. Navier Medical aims to reduce the impact of cardiovascular disease with the help of this funding.
Don't miss Navier Medical's next move
Get an email the moment Navier Medical raises, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech